Superworth

VivoSim Labs, INC. price to sales ratio VIVS

Market value divided by revenue over the last twelve months, since 2025.

Today, Nov 2, 2026
20.3×
Peer median
1.3×

VivoSim Labs, INC.'s price to sales ratio is 20.3× as of Nov 2, 2026.

The median for 10 healthcare stocks of a similar size is 1.3×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far20.3×9.2×54.4×
202537.4×20.5×76.7×

Against its peers

Companies in Healthcare nearest VivoSim Labs, INC.'s size, closest first, today.

Where VivoSim Labs, INC. ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on VivoSim Labs, INC.

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.